MYBL2


Summary: The protein encoded by this gene, a member of the MYB family of transcription factor genes, is a nuclear protein involved in cell cycle progression. The encoded protein is phosphorylated by cyclin A/cyclin-dependent kinase 2 during the S-phase of the cell cycle and possesses both activator and repressor activities. It has been shown to activate the cell division cycle 2, cyclin D1, and insulin-like growth factor-binding protein 5 genes. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2013].

NameOMIM IDEnsembl IDHGNC IDPHARMGKB IDMap Location
MYB proto-oncogene like 2MIM:601415Ensembl:ENSG00000101057HGNC:HGNC:7548PA3134820q13.12

Gene Categories:

TUMOR SUPPRESSOR

GO terms in MYBL2


Term TypeEvidence TypeGO Term IDGO Des.
BPIBAGO:0000278mitotic cell cycle
BPTASGO:0006357regulation of transcription by RNA polymerase II
BPIEAGO:0006366transcription by RNA polymerase II
BPIEAGO:0043525positive regulation of neuron apoptotic process
BPIBAGO:0045893positive regulation of transcription, DNA-templated
BPIDAGO:0045944positive regulation of transcription by RNA polymerase II
BPTASGO:0051726regulation of cell cycle
BPIEAGO:1990830cellular response to leukemia inhibitory factor
CCIDAGO:0005654nucleoplasm
CCTASGO:0005654nucleoplasm
CCIEAGO:0031523Myb complex
MFIDAGO:0000978RNA polymerase II proximal promoter sequence-specific DNA binding
MFISAGO:0000981RNA polymerase II transcription factor activity, sequence-specific DNA binding
MFISMGO:0000981RNA polymerase II transcription factor activity, sequence-specific DNA binding
MFNASGO:0000981RNA polymerase II transcription factor activity, sequence-specific DNA binding
MFIDAGO:0001077transcriptional activator activity, RNA polymerase II proximal promoter sequence-specific DNA binding
MFTASGO:0003700DNA-binding transcription factor activity
MFIPIGO:0005515protein binding

Gene expression in normal tissue: MYBL2

Gene-model tissue-cancer distribution: Bubble Plot

Gene-drug pathway distribution

Pathways in MYBL2


DatabasePathway IDPathway Des.
reactomeR-HSA-1362300Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1
reactomeR-HSA-1538133G0 and Early G1
reactomeR-HSA-156711Polo-like kinase mediated events
reactomeR-HSA-1640170Cell Cycle
reactomeR-HSA-1640170Cell Cycle
reactomeR-HSA-212436Generic Transcription Pathway
reactomeR-HSA-453274Mitotic G2-G2/M phases
reactomeR-HSA-453279Mitotic G1-G1/S phases
reactomeR-HSA-69275G2/M Transition
reactomeR-HSA-69278Cell Cycle, Mitotic
reactomeR-HSA-69278Cell Cycle, Mitotic
reactomeR-HSA-73857RNA Polymerase II Transcription
reactomeR-HSA-74160Gene expression (Transcription)
reactomeR-HSA-8864260Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors
reactomeR-HSA-8869496TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation
kegghsa04218Cellular senescence - Homo sapiens (human)
kegghsa05166HTLV-I infection - Homo sapiens (human)
pide2f_pathwayE2F transcription factor network
wikipathwaysWP1858Mitotic G1-G1-S phases
wikipathwaysWP2361Gastric Cancer Network 1
wikipathwaysWP4086Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors
wikipathwaysWP437EGF-EGFR Signaling Pathway

Gene-Drug: Aster Plot


Drug IDDrug NameModel Num.
iGMDRD883CIL55A1
iGMDRD154NSC237663
iGMDRD297Austocystin D3
iGMDRD61Kinetin riboside4
iGMDRD562Navitoclax3
iGMDRD79Gemcitabine3
iGMDRD6AM-5803
iGMDRD546BMS-7548072
iGMDRD1008SR-II-138A3
iGMDRD270Ciclosporin3
iGMDRD554CHEMBL14341373

Gene in drug-gene network: Network Plot

Gene-drug targets distribution

Gene Structure: PDB

Models in MYBL2

​​​​